Skip to main content

Table 1 Demographic and Clinical Characteristics of Participants

From: Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab

 

Retrospective

(n = 19)

Prospective

(n = 15)

P value

Male, n (%)

8 (42)

10 (67)

0.185

Black, n (%)

11 (58)

5 (33)

0.185

Mean Age at Tx, yr. ± SD

40 ± 12

38 ± 16

0.703

Mean Age at native FSGS Diagnosis, yr. ± SD

29 ± 8

30 ± 17

0.859

Median Duration on Dialysis, yr. (IQR)

2.5 (1.5, 8.0)

3.8 (1.3, 6.0)

0.888

Pre-Tx Urine, n (%)

13 (68)

6 (40)

0.165

Mean Pre-Transplant Proteinuria, g/g ± SD

9.43 ± 12

8.88 ± 7.32

0.673

Primary Pre-Tx Diagnosis, n (%)

 FSGS

17 (89)

15 (100)

0.492

 Other*

2 (11)

  

No. of Transplants, n (%)

 1

12 (63)

8 (53)

0.659

 2

4 (21)

5 (33)

 

 3

3 (16)

1 (7)

 

Living Donor, n (%)

12 (63)

11 (73)

0.469

 Related

5 (26)

3 (20)

 

 Unrelated

7 (37)

8 (53)

 

ABO-Incompatible Tx, n (%)

4 (21)

1 (7)

0.633

Median Time to Post-Tx FSGS, days (IQR)

31 (5, 238)

33 (5, 299)

0.589

Mean Proteinuria at time of Post-Tx FSGS, g/g ± SD

4.7 ± 3.6

3.2 ± 2.8

0.366

Mean Peak Proteinuria, g/g ± SD

10.94 ± 11.61

4.6 ± 3.25

0.061

Median Serum Creatinine at time of Post-Tx FSGS, mg/dL (IQR)

2.5 (1.7, 3.5)

1.5 (1.3, 2.4)

0.310

Median eGFR at time of Post-Txp FSGS, mg/dL (IQR)

32 (14, 44)

55 (29, 61)

0.943

Median TPE (IQR)

14 (10, 27)

10 (10, 19)

0.447

  1. yr year, SD standard deviation, IQR interquartile range, g gram, Tx transplant